Eve Health : Change of Director's Interest Notice x 3

About this update from Eve Health Group Limited

For personal use only Appendix 3Y Change of Director's Interest Notice Rule 3.19A.2 Appendix 3Y Change of Director's Interest Notice Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public. Introduced 30/9/2001. Name of entity EVE Health Group Limited ABN 89 106 523 611 We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act. Name of Director Alasdair Campbell Cooke Date of last notice 1 June 2020 Part 1 - Change of director's relevant interests in securities In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part. Direct or indirect interest Direct and Indirect Nature of indirect interest Glenlaren Pty Ltd (including registered holder) Hartree Pty Ltd Note: Provide details of the circumstances Mitchell River Group Pty Ltd giving rise to the relevant interest. Melissa Louise Cooke (Spouse) Date of change 31 December 2021 Direct 67,360,212 Ordinary Shares No. of securities held prior to 1,500,000 Performance Rights change 3,500,000 Unlisted option exercisable at $0.006 by 31 December 2021 Indirect 118,514,389 Ordinary Shares Class Unlisted option exercisable at $0.006 by 31 December 2021 Number acquired - Number disposed 3,500,000 Value/Consideration - Note: If consideration is non-cash, provide details and estimated valuation Direct 67,360,212 Ordinary Shares No. of securities held after change 1,500,000 Performance Rights Indirect 118,514,389 Ordinary Shares Nature of change Example: on-market trade, off-market trade, exercise Expiry of option of options, issue of securities under dividend reinvestment plan, participation in buy-back + See chapter 19 for defined terms. Appendix 3Y Page 1 Appendix 3Y Change of Director's Interest Notice Part 2 - Change of director's interests in contracts Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part. For personal use only Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change Part 3 - + Closed period Were the interests in the securities or contracts detailed above traded No during a + closed period where prior written clearance was required? If so, was prior written clearance provided to allow the trade to proceed N/A during this period? If prior written clearance was provided, on what date was this N/A provided? Appendix 3Y Page 2 For personal use only Appendix 3Y Change of Director's Interest Notice Rule 3.19A.2 Appendix 3Y Change of Director's Interest Notice Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public. Introduced 30/9/2001. Name of entity EVE Health Group Limited ABN 89 106 523 611 We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act. Name of Director George Cameron-Dow Date of last notice 1 June 2020 Part 1 - Change of director's relevant interests in securities In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part. Direct or indirect interest Direct and Indirect Nature of indirect interest (including registered holder) Dhow Nominees Pty Ltd ATF Dhow Trust Note: Provide details of the circumstances giving rise to the relevant interest. Date of change 31 December 2021 Direct No. of securities held prior to 1,500,000 Performance Rights Indirect change 7,999,980 Ordinary Shares 2,000,000 Unlisted option exercisable at $0.006 by 31 December 2021 Class Unlisted option exercisable at $0.006 by 31 December 2021 Number acquired - Number disposed 2,000,000 Value/Consideration - Note: If consideration is non-cash, provide details and estimated valuation Direct No. of securities held after change 1,500,000 Performance Rights Indirect 7,999,980 Ordinary Shares Nature of change Expiry of option Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back + See chapter 19 for defined terms. Appendix 3Y Page 1 Appendix 3Y Change of Director's Interest Notice Part 2 - Change of director's interests in contracts Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part. For personal use only Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change Part 3 - + Closed period Were the interests in the securities or contracts detailed above traded No during a + closed period where prior written clearance was required? If so, was prior written clearance provided to allow the trade to proceed N/A during this period? If prior written clearance was provided, on what date was this N/A provided? Appendix 3Y Page 2 For personal use only Appendix 3Y Change of Director's Interest Notice Rule 3.19A.2 Appendix 3Y Change of Director's Interest Notice Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public. Introduced 30/9/2001. Name of entity EVE Health Group Limited ABN 89 106 523 611 We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act. Name of Director Gregory William Fry Date of last notice 26 November 2021 Part 1 - Change of director's relevant interests in securities In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part. Direct or indirect interest Direct and Indirect Nature of indirect interest The Fry Family Superfund (including registered holder) Abigail Fry (spouse) Note: Provide details of the circumstances giving rise to the relevant interest. Date of change 29-31 December 2021 Direct 4,141,667 Ordinary Shares 18,000,000 Performance Rights No. of securities held prior to 3,333,332 Unlisted options exercisable at $0.006 by 31 December 2021 change 16,000,000 Unlisted options exercisable at $0.016 by 26 November 2024 Indirect 27,788,066 Ordinary Shares (Super Fund) 45,760,124 Ordinary Shares (Abigail Fry) Class Ordinary Shares Number acquired 1,800,000 Ordinary Shares (Super Fund) Number disposed 3,333,332 Unlisted options exercisable at $0.006 by 31 December 2021 Value/Consideration $7,200 Note: If consideration is non-cash, provide details and estimated valuation Direct 4,141,667 Ordinary Shares No. of securities held after 18,000,000 Performance Rights 16,000,000 Unlisted options exercisable at $0.016 by 26 November 2024 change Indirect 29,588,066 Ordinary Shares (Super Fund) 45,760,124 Ordinary Shares (Abigail Fry) + See chapter 19 for defined terms. Appendix 3Y Page 1 This is an excerpt of the original content. To continue reading it, access the original document here .

View stock analysis, news, and events for Eve Health Group Limited